Description:
A ticket is required for participation in this small interactive session: Register online here.
As of 2019, the ADA reported that over 37 million Americans were living with diabetes and 1.4 million new cases are being added to the tally every year. The CDC reported diabetes as the 8th leading cause of death while the highest cause of death was heart disease. Based on these numbers, PAs in primary care will undoubtedly care for patients with diabetes, heart disease, or both conditions every day and are uniquely positioned to reduce complications using treatments that improve outcomes. Keeping up with the ever-changing landscape of recommendations from major authorities can be a daunting task. By using real-life case scenarios in this workshop, PAs can navigate new guidelines and arrive at the best care plan for patients with varying degrees of disease, while addressing the health inequities that affect treatment selection.
Learning Objectives:
At the conclusion of this session, participants should be able to:
⦁ Identify patients with, or at high-risk of, diabetes and cardiovascular disease with screening methodologies from the USPSTF and other authorities
⦁ Interpret current diagnostic guidelines for cardiovascular disease from ACC/AHA and diabetes from ADA and the AACE
⦁ Develop individualized treatment plans using shared-decision approaches rooted in evidence-based pharmacotherapeutics including the latest agents such as SGLT2-inhibitors, GLP1-receptor agonists, and PCSK9 inhibitors
⦁ Counsel and motivate diverse patient populations with culturally informed lifestyle modifications while considering social determinants of health
CME Number:
H24121
Type:
CME
